Young Adult Tobacco/Nicotine and Cannabis Co-use
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Jan 25, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how tobacco and cannabis use affect each other, especially during attempts to quit using tobacco products. The research aims to understand the behaviors and choices people make when they try to stop using nicotine or tobacco while still using cannabis. If you're between 18 and 25 years old and have been using tobacco products (like cigarettes or vaping) and cannabis regularly, you might be eligible to participate. You don’t have to be interested in quitting cannabis to join the study.
Participants will receive help to quit using tobacco or nicotine for 12 weeks, and all activities will be done online, so there’s no need for in-person visits. To qualify, you need to use tobacco at least 20 days out of the last 30 and cannabis at least 10 days in that same timeframe. You’ll also need to provide some quick tests to show you’re using these substances. This study is being conducted by the Medical University of South Carolina, and it’s a great opportunity to get support while contributing to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18 and 25 years old
- • Must use at least one nicotine or tobacco product (nicotine vaping and/or cigarettes) on at least 20 out of the past 30 days for at least the past 3 months
- • Must express interest in nicotine cessation (all products)
- • Must submit a positive instant-read, oral fluid cotinine sample prior to enrollment
- • Must report use of cannabis on at least 10 out of the past 30 days
- • Must submit a positive instant-read cannabinoid test prior to enrollment
- • Must be able to provide informed consent
- Exclusion Criteria:
- • Any significant or acutely unstable medical, psychiatric, or substance use problem that would contraindicate research, interfere with safety, compromise data integrity, or preclude consistent study participation
- • Pregnant (self-report) or trying to become pregnant
- • Self-reported use of medications with smoking cessation efficacy
- • Immediate interest in cannabis cessation or treatment
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported